HMMJ:CA:TSX-Horizons Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 10.27

Change

0.00 (0.00)%

Market Cap

CAD 0.08B

Volume

3.18K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.28 (+0.75%)

CAD 2.55B
ZWU:CA BMO Covered Call Utilities ETF

+0.07 (+0.67%)

CAD 1.80B
TXF:CA First Asset Tech Giants Covere..

+0.02 (+0.10%)

CAD 0.66B
XIT:CA iShares S&P/TSX Capped Informa..

+0.07 (+0.14%)

CAD 0.63B
XHC:CA iShares Global Healthcare (CAD..

+0.44 (+0.61%)

CAD 0.60B
HTA:CA Tech Achievers Growth & Income..

+0.12 (+0.68%)

CAD 0.58B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.05 (+0.25%)

CAD 0.42B
CWW:CA iShares Global Water Common Cl..

-0.26 (-0.46%)

CAD 0.35B
HHL:CA Harvest Healthcare Leaders Inc..

+0.04 (+0.48%)

CAD 0.33B
ZUH:CA BMO Equal Weight US Health Car..

-0.13 (-0.19%)

CAD 0.30B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.55% 93% A 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.55% 93% A 74% C
Trailing 12 Months  
Capital Gain 4.16% 47% F 52% F
Dividend Return 1.93% 60% D- 32% F
Total Return 6.09% 40% F 52% F
Trailing 5 Years  
Capital Gain -76.22% 6% D- 6% D-
Dividend Return 4.72% 38% F 20% F
Total Return -71.50% 6% D- 6% D-
Average Annual (5 Year Horizon)  
Capital Gain -10.59% 6% D- 6% D-
Dividend Return -8.20% 6% D- 7% C-
Total Return 2.39% 66% D+ 63% D
Risk Return Profile  
Volatility (Standard Deviation) 42.93% 9% A- 21% F
Risk Adjusted Return -19.11% 9% A- 23% F
Market Capitalization 0.08B 54% F 33% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.